View More View Less
  • 1 Research and Development Center, Indian Immunologicals Limited, Rakshapuram, Gachibowli, Hyderabad, Andhra Pradesh, 500032, India
Restricted access

Abstract

Recombinant antibody fragments such as Fab, scFv, diabodies, triabodies, single domain antibodies and minibodies have recently emerged as potential alternatives to monoclonal antibodies, which can be engineered using phage display technology. These antibodies match the strengths of conventionally produced monoclonal antibodies and offer advantages for the development of immunodiagnostic kits and assays. These fragments not only retain the specificity of the whole monoclonal antibodies but also easy to express and produce in prokaryotic expression system. Further, these antibody fragments are genetically stable, less expensive, easy to modify in response to viral mutations and safer than monoclonal antibodies for use in diagnostic and therapeutic applications. This review describes the potential of antibody fragments generated using phage display and their use as diagnostic reagents.

  • 1. A Casadevall MD Scharff 1994 Serum therapy revisited: animal models of infection and development of passive antibody therapy Antimicrob Agents Chemother 38 1695 1702.

    • Search Google Scholar
    • Export Citation
  • 2. A Casadevall 1999 Passive antibody therapies: progress and continuing challenges Clin Immunol 93 5 15.

  • 3. SB Levy 1994 Drug resistance: the new apocalypse (special issue) Trends Microbiol 2 341 425.

  • 4. C A Arias BE Murray 2009 Antibiotic-resistant bugs in the 21st century — a clinical super-challenge New Engl J Med 3605 439 443.

  • 5. MA Keller ER Stiehm 2000 Passive immunity in prevention and treatment of infectious diseases Clin Microbiol Rev 13 602 614.

  • 6. A Casadevall E Dadachova LA Pirofski 2004 Passive antibody therapy for infectious diseases Nat Rev Microbiol 2 695 703.

  • 7. CA Borrebaeck 2000 Antibodies in diagnostics- from immunoassays to protein chips Immunol Today 218 379 382.

  • 8. MZ Siddiqui 2010 Monoclonal antibodies in diagnostics; an appraisal Indian J Pharm Sci 721 12 17.

  • 9. SD Jayasena 1999 Aptamers: an emerging class of molecules that rival antibodies in diagnostics Clin Chem 459 1628 1650.

  • 10. G Köhler C Milstein 1975 Continuous cultures of fused cells secreting antibody of predefined specificity Nature 256 495 497.

  • 11. G Jaffers TC Fuller AB Cosimi PS Russell HJ Winn RB Colvin 1986 Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression Transplantation 41 572 578.

    • Search Google Scholar
    • Export Citation
  • 12. H Schellekens 2002 Immunogenicity of therapeutic proteins: clinical implications and future prospects Clin Ther 24 1720 1740.

  • 13. A Skerra A Plückthun 1988 Assembly of a functional immunoglobulin Fv fragment in Escherichia coli Science 240 1038 1041.

  • 14. M Better CP Chang RR Robinson AH Horwitz 1988 Escherichia coli secretion of an active chimeric antibody fragment Science 240 1041 1043.

    • Search Google Scholar
    • Export Citation
  • 15. GP Smith 1985 Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface Science 228 1315 1317.

    • Search Google Scholar
    • Export Citation
  • 16. T Clackson HR Hoogenboom AD Griffiths G Winter 1991 Making antibody fragments using phage display libraries Nature 352 624 628.

  • 17. JD Marks HR Hoogenboom TP Bonnet J McCafferty G Griffiths AD Winter 1991 By-passing immunization J Mol Biol 222 581 597.

  • 18. TJ Vaughan AJ Williams K Pritchard JK Osbourn AR Pope JC Earnshaw J McCafferty RA Hodits J Wilton KS Johnson 1996 Human antibodies with sub-nanomolar affinities isolated from a large nonimmunised phage display library Nat Biotechnol 14 309 314.

    • Search Google Scholar
    • Export Citation
  • 19. AS Perelson GF Oster 1979 Theoretical studies of clonal selection: minimal antibody repertoire size and reliability of self-non-self discrimination J Theor Biol 81 645 670.

    • Search Google Scholar
    • Export Citation
  • 20. L Xu BQ Jin DM Fan 2003 Selection and identification of mimic epitopes for gastric cancer-associated antigen MG7 Ag Mol Cancer Ther 2 301 306.

    • Search Google Scholar
    • Export Citation
  • 21. F Rahbarizadeh MJ Rasaee M Forouzandeh Moghadam AA Allameh E Sadroddiny 2004 Production of novel recombinant single-domain antibodies against tandem repeat region of MUC1 mucin Hybridoma Hybridomics 23 151 159.

    • Search Google Scholar
    • Export Citation
  • 22. K Charlton WJ Harris AJ Porter 2001 The isolation of supersensitive anti-hapten antibodies from combinatorial antibody libraries derived from sheep Biosens Bioelectron 16 639 646.

    • Search Google Scholar
    • Export Citation
  • 23. T Okada M Akada T Fujita T Iwata Y Goto K Kido T Okada Y Matsuzaki K Kobayashi S Matsuno M Sunamura Y Kawakami 2006 A novel cancer testis antigen that is frequently expressed in pancreatic, lung and endometrial cancers Clin Cancer Res 12 191 197.

    • Search Google Scholar
    • Export Citation
  • 24. A Knappik L Ge A Honegger P Pack M Fischer A Wellnhofer ai]G, Hoess J Wölle A Plückthun B Virnekäs 2000 Fully synthetic human combinatorial libraries (HuCAL) based on modular consensus frameworks and CDRs randomised with trinucleotides J Mol Biol 296 57 86.

    • Search Google Scholar
    • Export Citation
  • 25. S Steidl O Ratsch B Brocks M Dürr E Thomassen-Wolf 2008 In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification Mol Immunol 46 135 144.

    • Search Google Scholar
    • Export Citation
  • 26. C Rothe S Urlinger C Löhning J Prassler Y Stark U Jäger B Hubner M Bardroff I Pradel M Boss R Bittlingmaier T Bataa C Frisch B Brocks A Honegger M Urban 2008 The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies J Mol Biol 376 1182 1200.

    • Search Google Scholar
    • Export Citation
  • 27. ZA Nagy B Hubner C Lohning R Rauchenberger S Reiffert E Thomassen-Wolf S Zahn S Leyer EM Schier A Zahradnik C Brunner M Stanglmaier S Anderson M Dunn M Hallek T Kretzschmar M Tesar 2002 Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells Nat Med 8 801 807.

    • Search Google Scholar
    • Export Citation
  • 28. J Sun J Pons CS Craik 2003 Potent and selective inhibition of membrane-type serine protease 1 by human single-chain antibodies Biochemistry 42 892 900.

    • Search Google Scholar
    • Export Citation
  • 29. D Griffiths SC Williams O Hartley IM Tomlinson P Waterhouse WL Crosby RE Kontermann PT Jones NM Low TJ Allison 1994 Isolation of high affinity human antibodies directly from large synthetic repertoires EMBO J 13 3245 3260.

    • Search Google Scholar
    • Export Citation
  • 30. D Sblattero A Bradbury 2000 Exploiting recombination in single bacteria to make large phage antibody libraries Nat Biotechnol 18 75 80.

    • Search Google Scholar
    • Export Citation
  • 31. HM Lorenz 2002 Technology evaluation: adalimumab, Abbott laboratories Curr Opin Mol Ther 4 185 190.

  • 32. J Albanell J Codony A Rovira B Mellado P Gascón 2003 Mechanism of action of anti-HER2 monoclonal antibodies: scientific update on trastuzumab and 2C4 Adv Exp Med Biol 532 253 268.

    • Search Google Scholar
    • Export Citation
  • 33. SL Smith 1996 Ten years of Orthoclone OKT3 (muromonab-CD3): a review J Transpl Coord 6 109 119.

  • 34. J Luka PM Arlen A Bristol 2011 Development of a serum biomarker assay that differentiates tumor-associated MUC5AC (NPC-1C ANTIGEN) from normal UC5AC J Biomed Biotechnol 934757.

    • Search Google Scholar
    • Export Citation
  • 35. D Colcher G Pavlinkova G Beresford BJM Booth A Choudhury SK Batra 1998 Pharmacokinetics and biodistribution of genetically-engineered antibodies Q J Nucl Med 42 225 241.

    • Search Google Scholar
    • Export Citation
  • 36. PJ Hudson 1999 Recombinant antibody constructs in cancer therapy Curr Opin Immunol 11 548 557.

  • 37. WHO 2001 Rabies. Fact sheet no. 99 WHO Geneva, Switzerland.

  • 38. MK Sudarshan SN Madhusudana BJ Mahendra NS Rao DH Ashwathnarayana S Abdul Rahman FX Meslin D Lobo K Ravikumar 2007 Gangaboraiah: Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey Int J Infect Dis 11 29 35.

    • Search Google Scholar
    • Export Citation
  • 39. LA Wilber MFA Aubert 1996 The NIH test for potency FX Meslin MM Kaplan H Koprowski Laboratory Techniques in Rabies 4th ed. WHO Geneva, Switzerland 360 368.

    • Search Google Scholar
    • Export Citation
  • 40. NV Sridevi MA Shukra B Neelakantam S Varaprasad Rao S Rajalakshmi T Dev Chandran, Nagarajan SB Nagendrakumar VA Srinivasan 2010 Recombinant diabody-based immunocapture enzyme-linked immunosorbent assay for quantification of rabies virus glycoprotein Clin Vaccine Immunol 17 1261 1268.

    • Search Google Scholar
    • Export Citation
  • 41. S Krugman R Ward JP Giles O Bodansky AM Jacobs 1959 Infectious hepatitis: detection of virus during the incubation period and in clinically inapparent infection N Engl J Med 261 729 734.

    • Search Google Scholar
    • Export Citation
  • 42. S Krugman R Ward JP Giles 1962 The natural history of infectious hepatitis Am J Med 32 717 728.

  • 43. S Krugman JP Giles J Hammond 1967 Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection JAMA 200 365 373.

    • Search Google Scholar
    • Export Citation
  • 44. JA Cuthbert 2001 Hepatitis A: old and new Clin Microbiol Rev 14 38 58.

  • 45. JT Stapleton 1999 Hepatitis A: biology, pathogenesis, epidemiology, clinical description and diagnosis S Spector Viral Hepatitis: Diagnosis, Therapy and Preventio Humana Press Totowa NJ 7 33.

    • Search Google Scholar
    • Export Citation
  • 46. AE Jones JL Smith SH Hindman ML Fleissner R Judelsohn SJ Englender H Tilson JE Maynard 1997 Foodborne hepatitis A infection: a report of two urban restaurant-associated outbreaks Am J Epidemiol 105 156 162.

    • Search Google Scholar
    • Export Citation
  • 47. TM Pollock D Reid 1969 Immunoglobulin for the prevention of infectious hepatitis in persons working overseas Lancet 1 281 283.

  • 48. F Hollinger J Ticehurst 1996 Hepatitis A virus BN Fields DM Knipe PM Howley Fields Virology 3rd edition Lippincott-Raven Publishers Philadelphia, Pennsylvania 735 782.

    • Search Google Scholar
    • Export Citation
  • 49. NV Sridevi A Shukra Madhaha B Neelakantam S Samuel D C Rajendra VA Srinivasan 2012 Development of recombinant single-chain variable fragment against hepatitis ai]A virus and its use in quantification of hepatitis A antigen Biologicals 40 299 308.

    • Search Google Scholar
    • Export Citation
  • 50. J Mestecky MW Russell CO Elson 1999 Intestinal IgA: novel views on its function in the defence of the largest mucosal surface Gut 44 2 5.

    • Search Google Scholar
    • Export Citation
  • 51. MB Mazanec C Kaetzel ME Lamm D Fletcher JG Nedrud 1992 Intracellular neutralization of virus by immunoglobulin A antibodies Proc Natl Acad Sci U S A 89 6901 6905.

    • Search Google Scholar
    • Export Citation
  • 52. MB Mazanec JG Nedrud CS Kaetzel ME Lamm 1993 A three-tiered view of the role of IgA in mucosal defense Immunol ai]Today 14 430 435.

    • Search Google Scholar
    • Export Citation
  • 53. MB Mazanec CL Coudret DR Fletcher 1995 Intracellular neutralization of influenza virus by immunoglobulin A antihemagglutinin monoclonal antibodies J Virol 69 1339 1343.

    • Search Google Scholar
    • Export Citation
  • 54. CS Kaetzel JK Robinson K Chintalacharuvu JP Vaerman ME Lamm 1991 The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA Proc Natl Acad Sci U S A 88 8796 8800.

    • Search Google Scholar
    • Export Citation
  • 55. NV Sridevi AM Shukra B Neelakantam J Anilkumar M Madhanmohan S Rajan VA Dev Chandran, Srinivasan 2014 Development of anti-bovine IgA single chain variable fragment and its application in diagnosis of foot and mouth disease Eur J Microbiol Immunol 4 34 44.

    • Search Google Scholar
    • Export Citation
  • 56. J Schoenborn CB Wilson 2007 Regulation of interferon-gamma during innate and adaptive immune responses Adv Immunol 96 41 101.

  • 57. K Schroder PJ Hertzog T Ravasi DA Hume 2004 Interferongamma: an overview of signals, mechanisms and functions J Leukocyte Biol 75 163 189.

    • Search Google Scholar
    • Export Citation
  • 58. R Dijkmans A Billiau 1988 Interferon-γ: a master key in the immune system Curr Opin Immunol 1 269 274.

  • 59. MR Ziai L Imberti M Kobayashi B Perussia G Trinchieri S Ferron 1986 Distinct functional domains on the recombinant human immune interferon molecule Cancer Res 46 6187 6190.

    • Search Google Scholar
    • Export Citation
  • 60. PW Gray DV Goeddel 1982 Structure of the human immune interferon gene Nature 298 859 863.

The author instruction is available in PDF.
Please, download the file from HERE.
 

Senior editors

Editor(s)-in-Chief: Dunay, Ildiko Rita

Editor(s)-in-Chief: Heimesaat, Markus M.

Vice Editor(s)-in-Chief: Fuchs, Anja

Editorial Board

Chair of the Editorial Board:
Jeffrey S. Buguliskis (Thomas Jefferson University, USA)

  • Jörn Albring (University of Münster, Germany)
  • Stefan Bereswill (Charité - University Medicine Berlin, Germany)
  • Dunja Bruder (University of Megdeburg, Germany)
  • Jan Buer (University of Duisburg, Germany)
  • Jeff Buguliskis (Thomas Jefferson University, USA)
  • Edit Buzas (Semmelweis University, Hungary)
  • Charles Collyer (University of Sydney, Australia)
  • Renato Damatta (UENF, Brazil)
  • Ivelina Damjanova (Semmelweis University, Hungary)
  • Maria Deli (Biological Research Center, HAS, Hungary)
  • Olgica Djurković-Djaković (University of Belgrade, Serbia)
  • Jean-Dennis Docquier (University of Siena, Italy)
  • Anna Erdei (Eötvös Loránd University, Hungary)
  • Zsuzsanna Fabry (University of Washington, USA)
  • Beniam Ghebremedhin (Witten/Herdecke University, Germany)
  • Nancy Guillen (Institute Pasteur, France)
  • Georgina L. Hold (University of Aberdeen, United Kingdom)
  • Ralf Ignatius (Charité - University Medicine Berlin, Germany)
  • Zsuzsanna Izsvak (MDC-Berlin, Germany)
  • Achim Kaasch (University of Cologne, Germany)
  • Tamás Laskay (University of Lübeck, Germany)
  • Oliver Liesenfeld (Roche, USA)
  • Shreemanta Parida (Vaccine Grand Challenge Program, India)
  • Matyas Sandor (University of Wisconsin, USA)
  • Ulrich Steinhoff (University of Marburg, Germany)
  • Michal Toborek (University of Miami, USA)
  • Mary Jo Wick (University of Gothenburg, Sweden)
  • Susanne A. Wolf (MDC-Berlin, Germany)

 

Dr. Dunay, Ildiko Rita
Magdeburg, Germany
E-mail: ildikodunay@gmail.com

Indexing and Abstracting Services:

  • PubMed Central
  • Scopus
  • ESCI
  • CABI

 

2020  
CrossRef Documents 23
WoS Cites 708
Wos H-index 27
Days from submission to acceptance 219
Days from acceptance to publication 176
Acceptance Rate 70%

2019  
WoS
Cites
558
CrossRef
Documents
24
Acceptance
Rate
92%

 

European Journal of Microbiology and Immunology
Publication Model Gold Open Access
Submission Fee none
Article Processing Charge 928 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Gold Open Access
Purchase per Title  

European Journal of Microbiology and Immunology
Language English
Size A4
Year of
Foundation
2011
Publication
Programme
2021 Volume 11
Volumes
per Year
1
Issues
per Year
4
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2062-509X (Print)
ISSN 2062-8633 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
May 2021 23 0 0
Jun 2021 12 0 0
Jul 2021 9 0 0
Aug 2021 11 0 0
Sep 2021 23 0 0
Oct 2021 24 0 0
Nov 2021 0 0 0